Researchers examine Real-World leukemia treatment costs and patterns
NCT ID NCT07150793
Summary
This study analyzed existing medical records to understand how chronic myeloid leukemia (CML) patients in Japan were treated with targeted medications called TKIs. Researchers examined treatment patterns, medication switches, healthcare visits, and costs for 754 patients between 2011 and 2019. The goal was to gather real-world information about how these treatments are used in everyday medical practice, not to test new treatments.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYELOID LEUKEMIA, CHRONIC are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Novartis
East Hanover, New Jersey, 07936, United States
Conditions
Explore the condition pages connected to this study.